Contribution: Industrial Research Assistance Program – Contributions to Firms
KMT Hepatech Inc.
$176,000.00
Establishing the production of fresh hepatocytes isolated from chimeric mouse with humanized liver
EF 2018-19 · 2018-11-01
Résumé
The project goal is to establish the sustainable production of PXB-Cells® (hepatocytes isolated from chimeric mouse with humanized liver) at KMT Hepatech facility in Edmonton. Quality Control procedures and packing process for shipment will be optimized.
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Edmonton|Edmonton, Alberta, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
873407811
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Modifications
Chaque version de l'entente telle que publiée, de la plus ancienne à la plus récente, avec son total à cette version. Le montant ci-dessus est le plus récent.
| Modification | Date | Exercice financier | Total |
|---|---|---|---|
| 0 | 2018-11-01 | 2018-19 | $116,000.00 |
| 2 | 2018-11-01 | 2018-19 | $166,000.00 |
| 3 | 2018-11-01 | 2018-19 | $176,000.00 |
Tel que publié
Additional Information
This agreement has been amended 1 time(s). The total amended value is 10,000 dollars. Edmonton Strathcona 48019
Additional Information (French)
Cet accord a été modifié 1 fois La valeur totale des modifications est de 10 000 dollars. Edmonton Strathcona 48019
Agreement End Date
2020-03-31
Agreement Number
916320
Agreement Start Date
2018-11-01
Agreement Title
Establishing the production of fresh hepatocytes isolated from chimeric mouse with humanized liver
Agreement Title (French)
Établir la production d'hépatocytes frais isolés de souris chimériques avec foie humanisé
Agreement Type
Contribution
Agreement Value
$176,000.00
Amendment Date
2020-02-18
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The project goal is to establish the sustainable production of PXB-Cells® (hepatocytes isolated from chimeric mouse with humanized liver) at KMT Hepatech facility in Edmonton. Quality Control procedures and packing process for shipment will be optimized.
Description (French)
L'objectif du projet est d'établir la production durable de PXB-Cells® (hépatocytes isolés de souris chimériques avec foie humanisé) dans les installations de KMT Hepatech à Edmonton. Les procédures de contrôle de la qualité et le processus d'emballage pour l'expédition seront optimisés.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Edmonton Mill Woods
Federal Riding (French)
Edmonton Mill Woods
Federal Riding Number
48017
NAICS Code
621510
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
873407811
Recipient City
Edmonton|Edmonton
Recipient Country
CA
Recipient Legal Name
KMT Hepatech Inc.
Recipient Postal Code
T6N 1H1
Recipient Province or Territory
AB
Recipient Type
F
Reference Number
172-2018-2019-Q3-916320
